Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial

Abstract Background There are no specific generally accepted therapies for the coronavirus disease 2019 (COVID-19). The full spectrum of COVID-19 ranges from asymptomatic disease to mild respiratory tract illness to severe pneumonia, acute respiratory distress syndrome (ARDS), multisystem organ fail...

Full description

Bibliographic Details
Main Authors: Jesús Villar, José M. Añón, Carlos Ferrando, Gerardo Aguilar, Tomás Muñoz, José Ferreres, Alfonso Ambrós, César Aldecoa, Fernando Suárez-Sipmann, Kevin E. Thorpe, Peter Jüni, Arthur S. Slutsky, the DEXA-COVID19 Network
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Trials
Subjects:
Acute respiratory distress syndrome
Coronavirus disease 19
COVID-19
Dexamethasone
Corticosteroids
Lung protective ventilation
Online Access:http://link.springer.com/article/10.1186/s13063-020-04643-1

Internet

http://link.springer.com/article/10.1186/s13063-020-04643-1

Similar Items